Literature DB >> 31673725

Xenobiotica-metabolizing enzymes in the lung of experimental animals, man and in human lung models.

F Oesch1,2, E Fabian3, Robert Landsiedel4.   

Abstract

The xenobiotic metabolism in the lung, an organ of first entry of xenobiotics into the organism, is crucial for inhaled compounds entering this organ intentionally (e.g. drugs) and unintentionally (e.g. work place and environmental compounds). Additionally, local metabolism by enzymes preferentially or exclusively occurring in the lung is important for favorable or toxic effects of xenobiotics entering the organism also by routes other than by inhalation. The data collected in this review show that generally activities of cytochromes P450 are low in the lung of all investigated species and in vitro models. Other oxidoreductases may turn out to be more important, but are largely not investigated. Phase II enzymes are generally much higher with the exception of UGT glucuronosyltransferases which are generally very low. Insofar as data are available the xenobiotic metabolism in the lung of monkeys comes closed to that in the human lung; however, very few data are available for this comparison. Second best rate the mouse and rat lung, followed by the rabbit. Of the human in vitro model primary cells in culture, such as alveolar macrophages and alveolar type II cells as well as the A549 cell line appear quite acceptable. However, (1) this generalization represents a temporary oversimplification born from the lack of more comparable data; (2) the relative suitability of individual species/models is different for different enzymes; (3) when more data become available, the conclusions derived from these comparisons quite possibly may change.

Entities:  

Keywords:  Cytochrome P450; Experimental animals; In vitro models; Lung; Phase II metabolism; Xenobiotic metabolism

Mesh:

Substances:

Year:  2019        PMID: 31673725     DOI: 10.1007/s00204-019-02602-7

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  10 in total

1.  In vitro airway models from mice, rhesus macaques, and humans maintain species differences in xenobiotic metabolism and cellular responses to naphthalene.

Authors:  Jacklyn Kelty; Nataliia Kovalchuk; Eric Uwimana; Lei Yin; Xinxin Ding; Laura Van Winkle
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-07-19       Impact factor: 6.011

2.  Predicting Regional Respiratory Tissue and Systemic Concentrations of Orally Inhaled Drugs through a Novel PBPK Model.

Authors:  Mayur K Ladumor; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2022-03-04       Impact factor: 3.579

Review 3.  Comparison of methods used for evaluation of mutagenicity/genotoxicity of model chemicals - parabens.

Authors:  J Chrz; B Hošíková; L Svobodová; D Očadlíková; H Kolářová; M Dvořáková; K Kejlová; L Malina; G Jírová; A Vlková; M Mannerström
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

4.  Effects of Real-Ambient PM2.5 Exposure on Lung Damage Modulated by Nrf2-/.

Authors:  Hao Ding; Menghui Jiang; Daochuan Li; Yanjie Zhao; Dianke Yu; Rong Zhang; Wen Chen; Jingbo Pi; Rui Chen; Lianhua Cui; Yuxin Zheng; Jinmei Piao
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

5.  Humanized liver TK-NOG mice with functional deletion of hepatic murine cytochrome P450s as a model for studying human drug metabolism.

Authors:  Shotaro Uehara; Yuichi Iida; Miyuki Ida-Tanaka; Motohito Goto; Kenji Kawai; Masafumi Yamamoto; Yuichiro Higuchi; Satoshi Ito; Riichi Takahashi; Hidetaka Kamimura; Mamoru Ito; Hiroshi Yamazaki; Mitsuo Oshimura; Yasuhiro Kazuki; Hiroshi Suemizu
Journal:  Sci Rep       Date:  2022-09-01       Impact factor: 4.996

6.  Nanoformulated Remdesivir with Extremely Low Content of Poly(2-oxazoline)-Based Stabilizer for Aerosol Treatment of COVID-19.

Authors:  Jacob D Ramsey; Ian E Stewart; Emily A Madden; Chaemin Lim; Duhyeong Hwang; Mark T Heise; Anthony J Hickey; Alexander V Kabanov
Journal:  Macromol Biosci       Date:  2022-05-26       Impact factor: 5.859

Review 7.  Localized delivery of nanomedicine and antibodies for combating COVID-19.

Authors:  Bin Tu; Yanrong Gao; Xinran An; Huiyuan Wang; Yongzhuo Huang
Journal:  Acta Pharm Sin B       Date:  2022-09-23       Impact factor: 14.903

Review 8.  Odorant Metabolism in Humans.

Authors:  Nicole Kornbausch; Marcel W Debong; Andrea Buettner; Jean-Marie Heydel; Helene M Loos
Journal:  Angew Chem Int Ed Engl       Date:  2022-07-28       Impact factor: 16.823

Review 9.  The role of cytochrome P450 (CYP) enzymes in hyperoxic lung injury.

Authors:  Rachel Stading; Xanthi Couroucli; Krithika Lingappan; Bhagavatula Moorthy
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-12-13       Impact factor: 4.481

10.  Pig Liver Esterases Hydrolyze Endocannabinoids and Promote Inflammatory Response.

Authors:  Qiongqiong Zhou; Bingfang Yan; Wanying Sun; Qi Chen; Qiling Xiao; Yuncai Xiao; Xiliang Wang; Deshi Shi
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.